RT Journal Article
SR Electronic
T1 The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003264
DO 10.1136/jitc-2021-003264
VO 10
IS 3
A1 Sum, Eva
A1 Rapp, Moritz
A1 Dürr, Harald
A1 Mazumdar, Alekhya
A1 Romero, Pedro J
A1 Trumpfheller, Christine
A1 Umaña, Pablo
YR 2022
UL http://jitc.bmj.com/content/10/3/e003264.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.